Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma
High-dose chemotherapy (HDT) with autologous stem cell transplantation (ASCT) is the standard of care for eligible multiple myeloma (MM) patients with improved progression-free and overall survival. We reviewed the ambulatory care unit pathway for MM patients who underwent HDT/ASCT in a tertiary hos...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Medknow Publications
2021-04-01
|
| סדרה: | Hematology/Oncology and Stem Cell Therapy |
| נושאים: | |
| גישה מקוונת: | https://journals.lww.com/10.1016/j.hemonc.2020.01.001 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
